A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.

ABSTRACT: Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by both neurological and systemic abnormalities. We examined the peripheral immune system and found widespread evidence of innate immune activation detectable in plasma throughout the course of HD. Interleukin 6 levels were increased in HD gene carriers with a mean of 16 years before the predicted onset of clinical symptoms. To our knowledge, this is the earliest plasma abnormality identified in HD. Monocytes from HD subjects expressed mutant huntingtin and were pathologically hyperactive in response to stimulation, suggesting that the mutant protein triggers a cell-autonomous immune activation. A similar pattern was seen in macrophages and microglia from HD mouse models, and the cerebrospinal fluid and stri

SUBMITTER: Bjorkqvist M 

PROVIDER: S-EPMC2525598 | biostudies-literature | 2008 Aug

REPOSITORIES: biostudies-literature